SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 213 filers reported holding SEATTLE GENETICS INC in Q4 2014. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,321,000 | +40.2% | 81,893 | +43.6% | 0.01% | +25.0% |
| Q3 2016 | $3,081,000 | +34.1% | 57,040 | +0.4% | 0.00% | +33.3% |
| Q2 2016 | $2,297,000 | +14.9% | 56,836 | -0.2% | 0.00% | 0.0% |
| Q1 2016 | $1,999,000 | -33.4% | 56,964 | -14.9% | 0.00% | -25.0% |
| Q4 2015 | $3,002,000 | +17.2% | 66,899 | +0.7% | 0.00% | +33.3% |
| Q3 2015 | $2,561,000 | -21.5% | 66,419 | -1.4% | 0.00% | -25.0% |
| Q2 2015 | $3,262,000 | +95.6% | 67,392 | +42.8% | 0.00% | +100.0% |
| Q1 2015 | $1,668,000 | +6.3% | 47,189 | -3.4% | 0.00% | 0.0% |
| Q4 2014 | $1,569,000 | -41.6% | 48,835 | -32.4% | 0.00% | -50.0% |
| Q3 2014 | $2,685,000 | -35.0% | 72,206 | -33.2% | 0.00% | -33.3% |
| Q2 2014 | $4,132,000 | +155.1% | 108,014 | +203.7% | 0.01% | +200.0% |
| Q1 2014 | $1,620,000 | +18.8% | 35,561 | +4.0% | 0.00% | 0.0% |
| Q4 2013 | $1,364,000 | -10.6% | 34,194 | -1.8% | 0.00% | -33.3% |
| Q3 2013 | $1,526,000 | +41.8% | 34,808 | +1.8% | 0.00% | +50.0% |
| Q2 2013 | $1,076,000 | – | 34,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |